APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intravenous Injection Immunoglobulin

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Intravenous Injection Immunoglobulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025182 pages

Choose your research edition.

Industry ResearchIntravenous Injection Immunoglobulin Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Intravenous Injection Immunoglobulin Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Intravenous Injection Immunoglobulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intravenous Injection Immunoglobulin Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Intravenous Injection Immunoglobulin Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Intravenous Injection Immunoglobulin market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Intravenous Injection Immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Intravenous Injection Immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Intravenous Injection Immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Intravenous Injection Immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Intravenous Injection Immunoglobulin include Boya-Bio, CTBB, Sinopharm, Beijing Tiantan Biological Products, Guangdong Shuagnlin Bio-pharmacy, Hualan Bio, Nanyue Biopharming, Shanghai RAAS and Weiguang Biological, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Intravenous Injection Immunoglobulin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Intravenous Injection Immunoglobulin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Intravenous Injection Immunoglobulin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Intravenous Injection Immunoglobulin market size, projected growth trends, production technologies, key applications, and end-use industries.

Intravenous Injection Immunoglobulin Segment by Company

Boya-Bio

CTBB

Sinopharm

Beijing Tiantan Biological Products

Guangdong Shuagnlin Bio-pharmacy

Hualan Bio

Nanyue Biopharming

Shanghai RAAS

Weiguang Biological

Intravenous Injection Immunoglobulin Segment by Type

5g/100ml

2.5g/50ml

1g/20ml

10g/200ml

1.25g/25ml

Intravenous Injection Immunoglobulin Segment by Application

Hospital

Clinic

Others

Intravenous Injection Immunoglobulin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Injection Immunoglobulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intravenous Injection Immunoglobulin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Injection Immunoglobulin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Intravenous Injection Immunoglobulin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Intravenous Injection Immunoglobulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Intravenous Injection Immunoglobulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Intravenous Injection Immunoglobulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Intravenous Injection Immunoglobulin Industry Trends Table 2. Intravenous Injection Immunoglobulin Industry Drivers Table 3. Intravenous Injection Immunoglobulin Industry Opportunities and Challenges Table 4. Intravenous Injection Immunoglobulin Industry Restraints Table 5. Global Intravenous Injection Immunoglobulin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Intravenous Injection Immunoglobulin Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Intravenous Injection Immunoglobulin Sales by Manufacturers (L) & (2021-2026) Table 8. Global Intravenous Injection Immunoglobulin Sales Market Share by Manufacturers Table 9. Global Intravenous Injection Immunoglobulin Average Sales Price (US$/ml) of Manufacturers (2021-2026) Table 10. Global Intravenous Injection Immunoglobulin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Intravenous Injection Immunoglobulin Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Intravenous Injection Immunoglobulin Manufacturers, Product Type & Application Table 13. Global Intravenous Injection Immunoglobulin Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Intravenous Injection Immunoglobulin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 5g/100ml Table 17. Major Manufacturers of 2.5g/50ml Table 18. Major Manufacturers of 1g/20ml Table 19. Major Manufacturers of 10g/200ml Table 20. Major Manufacturers of 1.25g/25ml Table 21. Global Intravenous Injection Immunoglobulin Sales by Type 2021 VS 2025 VS 2032 (L) Table 22. Global Intravenous Injection Immunoglobulin Sales by Type (2021-2026) & (L) Table 23. Global Intravenous Injection Immunoglobulin Sales by Type (2027-2032) & (L) Table 24. Global Intravenous Injection Immunoglobulin Sales Market Share by Type (2021-2026) Table 25. Global Intravenous Injection Immunoglobulin Sales Market Share by Type (2027-2032) Table 26. Global Intravenous Injection Immunoglobulin Revenue by Type 2021 VS 2025 VS 2032 (L) Table 27. Global Intravenous Injection Immunoglobulin Revenue by Type (2021-2026) & (L) Table 28. Global Intravenous Injection Immunoglobulin Revenue by Type (2027-2032) & (L) Table 29. Global Intravenous Injection Immunoglobulin Revenue Market Share by Type (2021-2026) Table 30. Global Intravenous Injection Immunoglobulin Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Hospital Table 32. Major Manufacturers of Clinic Table 33. Major Manufacturers of Others Table 34. Global Intravenous Injection Immunoglobulin Sales by Application 2021 VS 2025 VS 2032 (L) Table 35. Global Intravenous Injection Immunoglobulin Sales by Application (2021-2026) & (L) Table 36. Global Intravenous Injection Immunoglobulin Sales by Application (2027-2032) & (L) Table 37. Global Intravenous Injection Immunoglobulin Sales Market Share by Application (2021-2026) Table 38. Global Intravenous Injection Immunoglobulin Sales Market Share by Application (2027-2032) Table 39. Global Intravenous Injection Immunoglobulin Revenue by Application 2021 VS 2025 VS 2032 (L) Table 40. Global Intravenous Injection Immunoglobulin Revenue by Application (2021-2026) & (L) Table 41. Global Intravenous Injection Immunoglobulin Revenue by Application (2027-2032) & (L) Table 42. Global Intravenous Injection Immunoglobulin Revenue Market Share by Application (2021-2026) Table 43. Global Intravenous Injection Immunoglobulin Revenue Market Share by Application (2027-2032) Table 44. Global Intravenous Injection Immunoglobulin Sales by Region: 2021 VS 2025 VS 2032 (L) Table 45. Global Intravenous Injection Immunoglobulin Sales by Region (2021-2026) & (L) Table 46. Global Intravenous Injection Immunoglobulin Sales Market Share by Region (2021-2026) Table 47. Global Intravenous Injection Immunoglobulin Sales Forecasted by Region (2027-2032) & (L) Table 48. Global Intravenous Injection Immunoglobulin Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Intravenous Injection Immunoglobulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 50. North America Intravenous Injection Immunoglobulin Sales by Country (2021-2026) & (L) Table 51. North America Intravenous Injection Immunoglobulin Sales by Country (2027-2032) & (L) Table 52. Europe Intravenous Injection Immunoglobulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 53. Europe Intravenous Injection Immunoglobulin Sales by Country (2021-2026) & (L) Table 54. Europe Intravenous Injection Immunoglobulin Sales by Country (2027-2032) & (L) Table 55. Asia Pacific Intravenous Injection Immunoglobulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 56. Asia Pacific Intravenous Injection Immunoglobulin Sales by Country (2021-2026) & (L) Table 57. Asia Pacific Intravenous Injection Immunoglobulin Sales by Country (2027-2032) & (L) Table 58. South America, Middle East and Africa Intravenous Injection Immunoglobulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 59. South America, Middle East and Africa Intravenous Injection Immunoglobulin Sales by Country (2021-2026) & (L) Table 60. South America, Middle East and Africa Intravenous Injection Immunoglobulin Sales by Country (2027-2032) & (L) Table 61. Global Intravenous Injection Immunoglobulin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Intravenous Injection Immunoglobulin Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Intravenous Injection Immunoglobulin Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Intravenous Injection Immunoglobulin Revenue Market Share by Region (2021-2026) Table 65. Global Intravenous Injection Immunoglobulin Revenue Market Share by Region (2027-2032) Table 66. Boya-Bio Company Information Table 67. Boya-Bio Business Overview Table 68. Boya-Bio Intravenous Injection Immunoglobulin Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Boya-Bio Intravenous Injection Immunoglobulin Product Portfolio Table 70. Boya-Bio Recent Development Table 71. CTBB Company Information Table 72. CTBB Business Overview Table 73. CTBB Intravenous Injection Immunoglobulin Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. CTBB Intravenous Injection Immunoglobulin Product Portfolio Table 75. CTBB Recent Development Table 76. Sinopharm Company Information Table 77. Sinopharm Business Overview Table 78. Sinopharm Intravenous Injection Immunoglobulin Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Sinopharm Intravenous Injection Immunoglobulin Product Portfolio Table 80. Sinopharm Recent Development Table 81. Beijing Tiantan Biological Products Company Information Table 82. Beijing Tiantan Biological Products Business Overview Table 83. Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Product Portfolio Table 85. Beijing Tiantan Biological Products Recent Development Table 86. Guangdong Shuagnlin Bio-pharmacy Company Information Table 87. Guangdong Shuagnlin Bio-pharmacy Business Overview Table 88. Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Product Portfolio Table 90. Guangdong Shuagnlin Bio-pharmacy Recent Development Table 91. Hualan Bio Company Information Table 92. Hualan Bio Business Overview Table 93. Hualan Bio Intravenous Injection Immunoglobulin Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Hualan Bio Intravenous Injection Immunoglobulin Product Portfolio Table 95. Hualan Bio Recent Development Table 96. Nanyue Biopharming Company Information Table 97. Nanyue Biopharming Business Overview Table 98. Nanyue Biopharming Intravenous Injection Immunoglobulin Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Nanyue Biopharming Intravenous Injection Immunoglobulin Product Portfolio Table 100. Nanyue Biopharming Recent Development Table 101. Shanghai RAAS Company Information Table 102. Shanghai RAAS Business Overview Table 103. Shanghai RAAS Intravenous Injection Immunoglobulin Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Shanghai RAAS Intravenous Injection Immunoglobulin Product Portfolio Table 105. Shanghai RAAS Recent Development Table 106. Weiguang Biological Company Information Table 107. Weiguang Biological Business Overview Table 108. Weiguang Biological Intravenous Injection Immunoglobulin Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Weiguang Biological Intravenous Injection Immunoglobulin Product Portfolio Table 110. Weiguang Biological Recent Development Table 111. Key Raw Materials Table 112. Raw Materials Key Suppliers Table 113. Intravenous Injection Immunoglobulin Distributors List Table 114. Intravenous Injection Immunoglobulin Customers List Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Intravenous Injection Immunoglobulin Product Image Figure 2. Global Intravenous Injection Immunoglobulin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intravenous Injection Immunoglobulin Market Size (2021-2032) & (US$ Million) Figure 4. Global Intravenous Injection Immunoglobulin Sales (2021-2032) & (L) Figure 5. Global Intravenous Injection Immunoglobulin Average Price (US$/ml) & (2021-2032) Figure 6. Global Top 5 and 10 Intravenous Injection Immunoglobulin Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 5g/100ml Image Figure 9. 2.5g/50ml Image Figure 10. 1g/20ml Image Figure 11. 10g/200ml Image Figure 12. 1.25g/25ml Image Figure 13. Global Intravenous Injection Immunoglobulin Sales by Type (2021 VS 2025 VS 2032) & (L) Figure 14. Global Intravenous Injection Immunoglobulin Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Intravenous Injection Immunoglobulin Sales Market Share by Type (2021-2032) Figure 16. Global Intravenous Injection Immunoglobulin Revenue by Type (2021 VS 2025 VS 2032) & (L) Figure 17. Global Intravenous Injection Immunoglobulin Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Intravenous Injection Immunoglobulin Revenue Market Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Clinic Image Figure 21. Others Image Figure 22. Global Intravenous Injection Immunoglobulin Sales by Application (2021 VS 2025 VS 2032) & (L) Figure 23. Global Intravenous Injection Immunoglobulin Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Intravenous Injection Immunoglobulin Sales Market Share by Application (2021-2032) Figure 25. Global Intravenous Injection Immunoglobulin Revenue by Application (2021 VS 2025 VS 2032) & (L) Figure 26. Global Intravenous Injection Immunoglobulin Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Intravenous Injection Immunoglobulin Revenue Market Share by Application (2021-2032) Figure 28. North America Intravenous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (L) Figure 29. North America Intravenous Injection Immunoglobulin Sales Market Share by Country (2021-2032) Figure 30. U.S. Intravenous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (L) Figure 31. Canada Intravenous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (L) Figure 32. Mexico Intravenous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (L) Figure 33. Europe Intravenous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (L) Figure 34. Europe Intravenous Injection Immunoglobulin Sales Market Share by Country (2021-2032) Figure 35. Germany Intravenous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (L) Figure 36. France Intravenous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (L) Figure 37. U.K. Intravenous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (L) Figure 38. Italy Intravenous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (L) Figure 39. Netherlands Intravenous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (L) Figure 40. Asia Pacific Intravenous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (L) Figure 41. Asia Pacific Intravenous Injection Immunoglobulin Sales Market Share by Country (2021-2032) Figure 42. China Intravenous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (L) Figure 43. Japan Intravenous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (L) Figure 44. South Korea Intravenous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (L) Figure 45. Southeast Asia Intravenous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (L) Figure 46. India Intravenous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (L) Figure 47. Australia Intravenous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (L) Figure 48. South America, Middle East and Africa Intravenous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (L) Figure 49. South America, Middle East and Africa Intravenous Injection Immunoglobulin Sales Market Share by Country (2021-2032) Figure 50. Brazil Intravenous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (L) Figure 51. South Africa Intravenous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (L) Figure 52. Saudi Arabia Intravenous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (L) Figure 53. Turkey Intravenous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (L) Figure 54. Argentina Intravenous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (L) Figure 55. UAE Intravenous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (L) Figure 56. Egypt Intravenous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (L) Figure 57. Chile Intravenous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (L) Figure 58. Global Intravenous Injection Immunoglobulin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Intravenous Injection Immunoglobulin Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Intravenous Injection Immunoglobulin Revenue (2021-2032) & (US$ Million) Figure 61. North America Intravenous Injection Immunoglobulin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Intravenous Injection Immunoglobulin Revenue (2021-2032) & (US$ Million) Figure 63. Europe Intravenous Injection Immunoglobulin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Intravenous Injection Immunoglobulin Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Intravenous Injection Immunoglobulin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Intravenous Injection Immunoglobulin Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Intravenous Injection Immunoglobulin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Intravenous Injection Immunoglobulin Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Intravenous Injection Immunoglobulin Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 5g/100ml
  • 2.5g/50ml
  • 1g/20ml
  • 10g/200ml
  • 1.25g/25ml
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Boya-Bio
  • CTBB
  • Sinopharm
  • Beijing Tiantan Biological Products
  • Guangdong Shuagnlin Bio-pharmacy
  • Hualan Bio
  • Nanyue Biopharming
  • Shanghai RAAS
  • Weiguang Biological

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Intravenous Injection Immunoglobulin Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Intravenous Injection Immunoglobulin Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Intravenous Injection Immunoglobulin Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Intravenous Injection Immunoglobulin Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Intravenous Injection Immunoglobulin Market Dynamics
  1. 2.1 Intravenous Injection Immunoglobulin Industry Trends
  2. 2.2 Intravenous Injection Immunoglobulin Industry Drivers
  3. 2.3 Intravenous Injection Immunoglobulin Industry Opportunities and Challenges
  4. 2.4 Intravenous Injection Immunoglobulin Industry Restraints
3 Intravenous Injection Immunoglobulin Market by Manufacturers
  1. 3.1 Global Intravenous Injection Immunoglobulin Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Intravenous Injection Immunoglobulin Sales by Manufacturers (2021-2026)
  3. 3.3 Global Intravenous Injection Immunoglobulin Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Intravenous Injection Immunoglobulin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Intravenous Injection Immunoglobulin Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Intravenous Injection Immunoglobulin Manufacturers, Product Type & Application
  7. 3.7 Global Intravenous Injection Immunoglobulin Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Intravenous Injection Immunoglobulin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Intravenous Injection Immunoglobulin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Intravenous Injection Immunoglobulin Tier 1, Tier 2, and Tier 3
4 Intravenous Injection Immunoglobulin Market by Type
  1. 4.1 Intravenous Injection Immunoglobulin Type Introduction
  2. 4.1.1 5g/100ml
  3. 4.1.2 2.5g/50ml
  4. 4.1.3 1g/20ml
  5. 4.1.4 10g/200ml
  6. 4.1.5 1.25g/25ml
  7. 4.2 Global Intravenous Injection Immunoglobulin Sales by Type
  8. 4.2.1 Global Intravenous Injection Immunoglobulin Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Intravenous Injection Immunoglobulin Sales by Type (2021-2032)
  10. 4.2.3 Global Intravenous Injection Immunoglobulin Sales Market Share by Type (2021-2032)
  11. 4.3 Global Intravenous Injection Immunoglobulin Revenue by Type
  12. 4.3.1 Global Intravenous Injection Immunoglobulin Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Intravenous Injection Immunoglobulin Revenue by Type (2021-2032)
  14. 4.3.3 Global Intravenous Injection Immunoglobulin Revenue Market Share by Type (2021-2032)
5 Intravenous Injection Immunoglobulin Market by Application
  1. 5.1 Intravenous Injection Immunoglobulin Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Intravenous Injection Immunoglobulin Sales by Application
  6. 5.2.1 Global Intravenous Injection Immunoglobulin Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Intravenous Injection Immunoglobulin Sales by Application (2021-2032)
  8. 5.2.3 Global Intravenous Injection Immunoglobulin Sales Market Share by Application (2021-2032)
  9. 5.3 Global Intravenous Injection Immunoglobulin Revenue by Application
  10. 5.3.1 Global Intravenous Injection Immunoglobulin Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Intravenous Injection Immunoglobulin Revenue by Application (2021-2032)
  12. 5.3.3 Global Intravenous Injection Immunoglobulin Revenue Market Share by Application (2021-2032)
6 Global Intravenous Injection Immunoglobulin Sales by Region
  1. 6.1 Global Intravenous Injection Immunoglobulin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Intravenous Injection Immunoglobulin Sales by Region (2021-2032)
  3. 6.2.1 Global Intravenous Injection Immunoglobulin Sales by Region (2021-2026)
  4. 6.2.2 Global Intravenous Injection Immunoglobulin Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Intravenous Injection Immunoglobulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Intravenous Injection Immunoglobulin Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Intravenous Injection Immunoglobulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Intravenous Injection Immunoglobulin Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Intravenous Injection Immunoglobulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Intravenous Injection Immunoglobulin Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Intravenous Injection Immunoglobulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Intravenous Injection Immunoglobulin Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Intravenous Injection Immunoglobulin Revenue by Region
  1. 7.1 Global Intravenous Injection Immunoglobulin Revenue by Region
  2. 7.1.1 Global Intravenous Injection Immunoglobulin Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Intravenous Injection Immunoglobulin Revenue by Region (2021-2026)
  4. 7.1.3 Global Intravenous Injection Immunoglobulin Revenue by Region (2027-2032)
  5. 7.1.4 Global Intravenous Injection Immunoglobulin Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Intravenous Injection Immunoglobulin Revenue (2021-2032)
  8. 7.2.2 North America Intravenous Injection Immunoglobulin Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Intravenous Injection Immunoglobulin Revenue (2021-2032)
  11. 7.3.2 Europe Intravenous Injection Immunoglobulin Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Intravenous Injection Immunoglobulin Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Intravenous Injection Immunoglobulin Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Intravenous Injection Immunoglobulin Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Intravenous Injection Immunoglobulin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Boya-Bio
  2. 8.1.1 Boya-Bio Company Information
  3. 8.1.2 Boya-Bio Business Overview
  4. 8.1.3 Boya-Bio Intravenous Injection Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Boya-Bio Intravenous Injection Immunoglobulin Product Portfolio
  6. 8.1.5 Boya-Bio Recent Developments
  7. 8.2 CTBB
  8. 8.2.1 CTBB Company Information
  9. 8.2.2 CTBB Business Overview
  10. 8.2.3 CTBB Intravenous Injection Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CTBB Intravenous Injection Immunoglobulin Product Portfolio
  12. 8.2.5 CTBB Recent Developments
  13. 8.3 Sinopharm
  14. 8.3.1 Sinopharm Company Information
  15. 8.3.2 Sinopharm Business Overview
  16. 8.3.3 Sinopharm Intravenous Injection Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sinopharm Intravenous Injection Immunoglobulin Product Portfolio
  18. 8.3.5 Sinopharm Recent Developments
  19. 8.4 Beijing Tiantan Biological Products
  20. 8.4.1 Beijing Tiantan Biological Products Company Information
  21. 8.4.2 Beijing Tiantan Biological Products Business Overview
  22. 8.4.3 Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Product Portfolio
  24. 8.4.5 Beijing Tiantan Biological Products Recent Developments
  25. 8.5 Guangdong Shuagnlin Bio-pharmacy
  26. 8.5.1 Guangdong Shuagnlin Bio-pharmacy Company Information
  27. 8.5.2 Guangdong Shuagnlin Bio-pharmacy Business Overview
  28. 8.5.3 Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Product Portfolio
  30. 8.5.5 Guangdong Shuagnlin Bio-pharmacy Recent Developments
  31. 8.6 Hualan Bio
  32. 8.6.1 Hualan Bio Company Information
  33. 8.6.2 Hualan Bio Business Overview
  34. 8.6.3 Hualan Bio Intravenous Injection Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hualan Bio Intravenous Injection Immunoglobulin Product Portfolio
  36. 8.6.5 Hualan Bio Recent Developments
  37. 8.7 Nanyue Biopharming
  38. 8.7.1 Nanyue Biopharming Company Information
  39. 8.7.2 Nanyue Biopharming Business Overview
  40. 8.7.3 Nanyue Biopharming Intravenous Injection Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Nanyue Biopharming Intravenous Injection Immunoglobulin Product Portfolio
  42. 8.7.5 Nanyue Biopharming Recent Developments
  43. 8.8 Shanghai RAAS
  44. 8.8.1 Shanghai RAAS Company Information
  45. 8.8.2 Shanghai RAAS Business Overview
  46. 8.8.3 Shanghai RAAS Intravenous Injection Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Shanghai RAAS Intravenous Injection Immunoglobulin Product Portfolio
  48. 8.8.5 Shanghai RAAS Recent Developments
  49. 8.9 Weiguang Biological
  50. 8.9.1 Weiguang Biological Company Information
  51. 8.9.2 Weiguang Biological Business Overview
  52. 8.9.3 Weiguang Biological Intravenous Injection Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Weiguang Biological Intravenous Injection Immunoglobulin Product Portfolio
  54. 8.9.5 Weiguang Biological Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Intravenous Injection Immunoglobulin Value Chain Analysis
  2. 9.1.1 Intravenous Injection Immunoglobulin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Intravenous Injection Immunoglobulin Production Mode & Process
  6. 9.2 Intravenous Injection Immunoglobulin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Intravenous Injection Immunoglobulin Distributors
  9. 9.2.3 Intravenous Injection Immunoglobulin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst